SCHEMBL19205729

SCHEMBL19205729

CCC(F)(F)c1ccc(CC(=O)Nc2ccc(-c3nccnc3NC(C)c3cccc(Cl)c3)cc2)cc1

nearest known ligand 0.43

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ RORC P51449 9/20 0.43
▸ RET P07949 2/20 0.41
▸ MDM2 Q00987 2/20 0.41
▸ ADRB2 P07550 1/20 0.41
▸ ADRB1 P08588 1/20 0.41
▸ ADRB3 P13945 1/20 0.41
▸ P2RY14 Q15391 1/20 0.38
▸ NR2E1 Q9Y466 1/20 0.38
▸ WNT3A P56704 1/20 0.38
▸ CYP2D6 P10635 1/20 0.38
▸ PSEN1 P49768 1/20 0.38
▸ PSEN2 P49810 1/20 0.38
▸ APH1B Q8WW43 1/20 0.38
▸ NCSTN Q92542 1/20 0.38
▸ APH1A Q96BI3 1/20 0.38
▸ PSENEN Q9NZ42 1/20 0.38
▸ P2RX4 Q99571 1/20 0.38
▸ KDM4E B2RXH2 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19205728 1.00 RORC (0.43) RORCRETMDM2ADRB2ADRB1
SCHEMBL19205756 0.90 MEN1 (0.42) RORCRETNR2E1CYP2D6PSEN1
SCHEMBL19205758 0.90 MEN1 (0.42) RORCRETNR2E1CYP2D6PSEN1
SCHEMBL19205643 0.90 RORC (0.44) RORCRETWNT3ACYP2D6PSEN1
SCHEMBL19205807 0.90 RORC (0.44) RORCRETWNT3ACYP2D6PSEN1
SCHEMBL19205684 0.90 RORC (0.44) RORCRETWNT3ACYP2D6PSEN1
SCHEMBL19205595 0.85 KCNJ5 (0.42) RORCRETNR2E1WNT3ACYP2D6
SCHEMBL19205594 0.85 KCNJ5 (0.42) RORCRETNR2E1WNT3ACYP2D6
SCHEMBL19205582 0.83 WNT3A (0.42) RORCRETWNT3ACYP2D6PSEN1
SCHEMBL19205808 0.83 RORC (0.39) RORCWNT3ACYP2D6PSEN1PSEN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-108026050-B Novel compounds as ROR gamma modulators 格兰马克药品股份有限公司 2021-04-30 — — CN claimed
EP-3331863-B1 NOVEL COMPOUNDS AS ROR GAMMA MODULATORS GLENMARK PHARMACEUTICALS SA (CH) 2020-03-11 — — EP claimed
US-10344024-B2 Compounds as ROR gamma modulators GLENMARK PHARMACEUTICALS S.A. (CH) 2019-07-09 — — US claimed
US-20180237428-A1 NOVEL COMPOUNDS AS ROR GAMMA MODULATORS GLENMARK PHARMACEUTICALS SA (CH) 2018-08-23 — — US claimed
US-9975887-B2 Compounds as ROR gamma modulators GLENMARK PHARMACEUTICALS S.A. (CH) 2018-05-22 — — US claimed
US-20170233380-A1 NOVEL COMPOUNDS AS ROR GAMMA MODULATORS GLENMARK PHARMACEUTICALS S.A. (CH) 2017-08-17 — — US claimed
EP-3686187-A1 PROCESS FOR THE PREPARATION OF ROR GAMMA MODULATORS Glenmark Pharmaceuticals S.A. (CH) 2020-07-29 — — EP disclosed
EP-3331863-B1 NOVEL COMPOUNDS AS ROR GAMMA MODULATORS GLENMARK PHARMACEUTICALS SA (CH) 2020-03-11 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10344024-B2 Compounds as ROR gamma modulators RORB, RORA, RORC RORC 3/4885RET 358/4885MDM2 2518/4885
US-20180237428-A1 NOVEL COMPOUNDS AS ROR GAMMA MODULATORS RORB, RORA, RORC RORC 3/4885RET 254/4885MDM2 2697/4885
US-20170233380-A1 NOVEL COMPOUNDS AS ROR GAMMA MODULATORS RORB, RORA, RORC RORC 3/4885RET 359/4885MDM2 2581/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback